BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31689915)

  • 21. Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target.
    Loeser H; Waldschmidt D; Kuetting F; Heydt C; Zander T; Plum P; Alakus H; Buettner R; Quaas A
    Mol Clin Oncol; 2017 May; 6(5):639-642. PubMed ID: 28529740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
    Travaglini L; Vian L; Billi M; Grignani F; Nervi C
    Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
    Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
    Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells.
    Lau KM; Mok SC; Ho SM
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5722-7. PubMed ID: 10318951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells.
    Kala R; Tollefsbol TO
    PLoS One; 2016; 11(5):e0155057. PubMed ID: 27159275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.
    Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Lu H; Sisinni L; Lettini G; Gabra H; Landriscina M; Esposito F
    Cell Death Dis; 2016 Dec; 7(12):e2522. PubMed ID: 27977010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches.
    Sabatino M; Rotili D; Patsilinakos A; Forgione M; Tomaselli D; Alby F; Arimondo PB; Mai A; Ragno R
    J Comput Aided Mol Des; 2018 Mar; 32(3):435-458. PubMed ID: 29335872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα
    Shea MP; O'Leary KA; Fakhraldeen SA; Goffin V; Friedl A; Wisinski KB; Alexander CM; Schuler LA
    Cancer Res; 2018 Apr; 78(7):1672-1684. PubMed ID: 29363543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines.
    Oktyabri D; Ishimura A; Tange S; Terashima M; Suzuki T
    Biochimie; 2016 Apr; 123():20-31. PubMed ID: 26783998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apigenin Inhibits the Histamine-Induced Proliferation of Ovarian Cancer Cells by Downregulating ERα/ERβ Expression.
    Liu M; Zhang Y; Xu Q; Liu G; Sun N; Che H; He T
    Front Oncol; 2021; 11():682917. PubMed ID: 34568014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition.
    Serresi M; Kertalli S; Li L; Schmitt MJ; Dramaretska Y; Wierikx J; Hulsman D; Gargiulo G
    Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33627422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptors as novel therapeutic targets for ovarian cancer.
    Muccioli M; Sprague L; Nandigam H; Pate M; Benencia F
    ISRN Oncol; 2012; 2012():642141. PubMed ID: 22530148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide DNA methylation changes upon DOT1L inhibition in hormone-responsive breast cancer cells.
    Giurato G; Terenzi I; Chiuso F; Salvati A; Rizzo F; Tarallo R; Weisz A; Nassa G
    Front Cell Dev Biol; 2023; 11():1308025. PubMed ID: 38099289
    [No Abstract]   [Full Text] [Related]  

  • 37. Correction: The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
    Yang D; Xu P; Su H; Zhong W; Xu J; Su Z; Liu X
    Cell Death Dis; 2022 Feb; 13(2):153. PubMed ID: 35165258
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of Concern: The role of DOT1L in the proliferation and prognosis of gastric cancer.
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33821982
    [No Abstract]   [Full Text] [Related]  

  • 39. Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.
    Vatapalli R; Sagar V; Rodriguez Y; Zhao JC; Unno K; Pamarthy S; Lysy B; Anker J; Han H; Yoo YA; Truica M; Chalmers ZR; Giles F; Yu J; Chakravarti D; Carneiro B; Abdulkadir SA
    Nat Commun; 2020 Aug; 11(1):4153. PubMed ID: 32814769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer.
    Alexandrova E; Lamberti J; Saggese P; Pecoraro G; Memoli D; Cappa VM; Ravo M; Iorio R; Tarallo R; Rizzo F; Collina F; Cantile M; Bonito MD; Botti G; Nassa G; Weisz A; Giurato G
    Cells; 2020 Apr; 9(4):. PubMed ID: 32260128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.